Literature DB >> 692096

A comparison of three methods for obtaining articulatory responses.

E M DuBois, J E Bernthal.   

Abstract

This study compared speech-sound productions of 18 children with articulation errors obtained with three different speech-sampling methods. The same 20 stimulus words were elicited by each of three sampling methods: (1) Continuous Speech Task, (2) Modeled Continuous Speech Task, and (3) Spontaneous Picture-Naming Task. Subjects performed differently on each of the speaking tasks. Statistical treatment of the mean score data revealed that significantly more errors were elicited with the Continuous Speech Task than with the Modeled Continuous Speech Task or the Spontaneous Picture-Naming Task. In addition, significantly more errors were elicited with the Modeled Continuous Speech Task than the Spontaneous Picture-Naming Task. The Continuous Speech Task required the greatest amount of time to administer, followed by the Modeled Continuous Speech Task, and finally the Spontaneous Picture-Naming Task.

Entities:  

Mesh:

Year:  1978        PMID: 692096     DOI: 10.1044/jshd.4303.295

Source DB:  PubMed          Journal:  J Speech Hear Disord        ISSN: 0022-4677


  3 in total

1.  Longitudinal development of phonology and morphology in children with late-identified mild-moderate sensorineural hearing loss.

Authors:  Mary Pat Moeller; Elizabeth McCleary; Coille Putman; Amy Tyler-Krings; Brenda Hoover; Patricia Stelmachowicz
Journal:  Ear Hear       Date:  2010-10       Impact factor: 3.570

2.  Relationships between speech intelligibility and word articulation scores in children with hearing loss.

Authors:  David J Ertmer
Journal:  J Speech Lang Hear Res       Date:  2010-03-10       Impact factor: 2.297

3.  Protocol for the Connected Speech Transcription of Children with Speech Disorders: An Example from Childhood Apraxia of Speech.

Authors:  Catherine Barrett; Patricia McCabe; Sarah Masso; Jonathan Preston
Journal:  Folia Phoniatr Logop       Date:  2019-07-03       Impact factor: 0.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.